AMIX earnings date and last-quarter result: next report 2026-08-12, last quarter in line, P/E -0.06. Updated 2026-07-23.
Autonomix Medical (AMIX) Research Hub
Autonomix Medical (AMIX) trades on NASDAQ, US in the Healthcare (Medical - Devices) sector. As of 2026-10-26, shares last closed at 2.1 USD (-13.22%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -0.06, market cap 0.00B. This hub links to the full technical, earnings and options research available for AMIX.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Devices) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 2.1 USD (-13.22%) |
| 52-week range | 2.1 USD – 24.68 USD |
| Trend regime | Range |
| 14-day RSI | 2.1 (Oversold) |
| Trailing P/E | -0.06 |
| Market cap | 0.00B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-12 |
Available research for AMIX
Covered Call on AMIX: how it works, illustrative setup around the real 2.1 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on AMIX: how it works, illustrative setup around the real 2.1 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on AMIX: how it works, illustrative setup around the real 2.1 USD price, max profit/loss, breakeven and when to use it. Educational.
AMIX technical analysis: range, last 2.1 USD, RSI 2.1, 52w range 2.1 USD–24.68 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is AMIX in?
Autonomix Medical (AMIX) is classified under Healthcare (Medical - Devices), listed on NASDAQ, US.
Is AMIX in an uptrend or downtrend?
As of 2026-10-26, AMIX is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is AMIX's trailing P/E ratio?
AMIX's trailing P/E is -0.06, with a market cap of 0.00B. See the earnings research page for full valuation detail.
When does AMIX next report earnings?
AMIX is next scheduled to report earnings on 2026-08-12.